OrderMedications.org - buy hundreds cheap rx medicines online!

OrderMedications.org gives you the chance to buy neurontin tablets and quality Pain Medicine drugs at discount prices from the privacy of your home.

Generic Neurontin Gabapentin 300/400mg

Neurontin (gabapentin) is an anticonvulsant used to control various types of seizures in the treatment of epilepsy. It has also been used with some success in other conditions, including post poliomyelitis pain and amyotrophic lateral sclerosis. If Neurontin is taken with certain other drugs, the effects of either can be increased, decreased, or altered. The most serious side effect for adults taking this medicine is an allergic reaction characterized by swelling of the mouth, lips and tongue as well as hives and the closing of throat. The effect of gabapentin on cimetidine was not evaluated. Oral Contraceptive: Based on AUC and half-life, multiple-dose pharmacokinetic profiles of norethindrone and ethinyl estradiol following administration of tablets containing 2.5 mg of norethindrone acetate and 50 mcg of ethinyl estradiol were similar with and without coadministration of gabapentin (400 mg TID; N=13).

Package	Price	Per Pill	Order
300mg × 30 pills	$35.00	US $ 1.17
300mg × 60 pills	$65.00	US $ 1.08
300mg × 90 pills	$90.00	US $ 1.00
300mg × 120 pills	$110.00	US $ 0.92

Package	Price	Per Pill	Order
400mg × 30 pills	$40.00	US $ 1.33
400mg × 60 pills	$76.00	US $ 1.27
400mg × 90 pills	$110.00	US $ 1.22

Possible Side Effects Of Gabapentin:

Check with your doctor if any of these most COMMON side effects persist or become bothersome: Back pain; changes in vision (double or blurred vision); clumsiness; constipation; diarrhea; dizziness; drowsiness; dry mouth; nausea; stomach upset; tiredness; vomiting; weight gain. A second study compared primarily 1200 mg/day TID Neurontin with placebo, with additional Neurontin dosage groups (600 mg/day, 1800 mg/day) also studied for information regarding dose response. The responder rate was higher in the Neurontin 1200 mg/day group (16%) than in the placebo group (8%), but the difference was not statistically significant. The responder rate at 600 mg was also not significantly higher than in the placebo, but the rate in the 1800 mg group was statistically superior to the placebo rate.

Possible Food And Drug Interactions When Taking Neurontin

A third study compared Neurontin 900 mg/day TID and placebo. Clinical trials data do not indicate that routine monitoring of clinical laboratory parameters is necessary for the safe use of Neurontin. , Antidepressants, alcohol and other drugs that cause drowsiness - Neurontin may further increase the susceptibility of the patient to succumb to drowsiness and sleepy feeling. . Any medication taken in excess can have serious consequences. If you suspect an overdose, seek medical treatment immediately. It is not known whether gabapentin has the ability to increase cell proliferation in other cell types or in other species, including humans. Previous to clinical trials, all of these patients had at least 4 partial seizures a month, despite the use of one or more antiepileptic drugs.

Neurontin Side Effects

If you are pregnant or plan to become pregnant, tell your doctor immediately. The identity and function of this binding site remain to be elucidated. Any medication taken in excess can have serious consequences. The relevance of this finding to carcinogenic risk in humans is unclear. Studies designed to investigate the mechanism of gabapentin-induced pancreatic carcinogenesis in rats indicate that gabapentin stimulates DNA synthesis in rat pancreatic acinar cells in vitro and, thus, may be acting as a tumor promoter by enhancing mitogenic activity.

Warnings

The doses at which the effects occurred are approximately 1 to 5 times the maximum human dose of 3600 mg/day on a mg/m basis; the no-effect doses were approximately 3 times (Fertility and General Reproductive Performance study) and approximately equal to (Teratogenicity study) the maximum human dose on a mg/m basis. Other than hydroureter and hydronephrosis, the etiologies of which are unclear, the incidence of malformations was not increased compared to controls in offspring of mice, rats, or rabbits given doses up to 50 times (mice), 30 times (rats), and 25 times (rabbits) the human daily dose on a mg/kg basis, or 4 times (mice), 5 times (rats), or 8 times (rabbits) the human daily dose on a mg/m basis.

Mechanism Of Action

Safety and effectiveness of Neurontin(gabapentin) in the management of postherpetic neuralgia in pediatric patients have not been established. The most commonly observed adverse events associated with the use of Neurontinin adults, not seen at an equivalent frequency among placebo-treated patients, were dizziness, somnolence, and peripheral edema. Table 2 lists treatment-emergent signs and symptoms that occurred in at least 1% of Neurontin-treated patients with postherpetic neuralgia participating in placebo-controlled trials and that were numerically more frequent in the Neurontingroup than in the placebo group. The adverse events most commonly associated with withdrawal in patients greater than 12 years of age were somnolence (1.2%), ataxia (0.8%), fatigue (0.6%), nausea and/or vomiting (0.6%), and dizziness (0.6%).

Gabapentin Adverse Reactions

The most commonly observed adverse events reported with the use of Neurontinin combination with other antiepileptic drugs in pediatric patients 3 to 12 years of age, not seen at an equal frequency among placebo-treated patients, were viral infection, fever, nausea and/or vomiting, somnolence, and hostility Approximately 7% of the 2074 patients greater than 12 years of age and approximately 7% of the 449 pediatric patients 3 to 12 years of age who received Neurontinin premarketing clinical trials discontinued treatment because of an adverse event. Adverse events were usually mild to moderate in intensity. These categories are used in the listing below. The frequencies presented represent the proportion of the 2074 patients greater than 12 years of age exposed to Neurontinwho experienced an event of the type cited on at least one occasion while receiving Neurontin.